Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Acuity Brands
AYI
$10.8B
| $88.5M | 0.08% |
923,916
-57,800
| -6% | -$5.08M |
|
277
Liberty Global Class C
LBTYK
$3.41B
| $88.3M | 0.08% |
4,106,835
+3,041,420
| +285% | +$60.7M |
|
278
Mettler-Toledo International
MTD
$28.6B
| $88.3M | 0.08% |
109,628
-14,022
| -11% | -$10.4M |
|
279
Waste Management
WM
$90.6B
| $88.1M | 0.08% |
831,700
+358,011
| +76% | +$36.1M |
|
280
Liberty Global Class A
LBTYA
$3.49B
| $87.9M | 0.08% |
4,021,314
+1,230,887
| +44% | +$25.4M |
|
281
Capitol Federal Financial
CFFN
$1.09B
| $87.1M | 0.08% |
7,908,795
-296,700
| -4% | -$3.4M |
|
282
InterDigital
IDCC
$8.8B
| $86.7M | 0.07% |
1,531,567
-67,200
| -4% | -$3.57M |
|
283
Avista
AVA
$3.24B
| $86.7M | 0.07% |
2,381,522
-381,043
| -14% | -$15.1M |
|
|
CSGS
284
DELISTED
CSG Systems International
CSGS
| $86.1M | 0.07% |
2,079,456
-164,900
| -7% | -$7.55M |
|
285
Steel Dynamics
STLD
$37.7B
| $85.9M | 0.07% |
3,293,785
+331,600
| +11% | +$8.29M |
|
286
Republic Services
RSG
$65.9B
| $85.4M | 0.07% |
1,041,161
-253,044
| -20% | -$20.4M |
|
|
TXNM
287
TXNM Energy Inc
TXNM
$5.91B
| $85M | 0.07% |
2,210,600
-1,168,500
| -35% | -$46.7M |
|
288
Alphabet (Google) Class C
GOOG
$4.19T
| $84.9M | 0.07% |
1,201,700
-1,888,000
| -61% | -$127M |
|
289
Valvoline
VVV
$4.22B
| $84.4M | 0.07% |
4,365,851
-571,673
| -12% | -$9.7M |
|
290
Repligen
RGEN
$9.22B
| $83.8M | 0.07% |
678,033
+299,300
| +79% | +$35.2M |
|
291
Rayonier
RYN
$6.4B
| $83.8M | 0.07% |
3,725,760
-628,601
| -14% | -$13.7M |
|
292
CorVel
CRVL
$3.07B
| $83.5M | 0.07% |
3,534,930
-241,827
| -6% | -$4.76M |
|
293
RELX
RELX
$60.1B
| $83.5M | 0.07% |
3,545,100
+247,100
| +7% | +$5.65M |
|
294
Douglas Emmett
DEI
$1.93B
| $83.4M | 0.07% |
2,720,709
-1,161,900
| -30% | -$34.8M |
|
295
PLDT
PHI
$4.21B
| $83.1M | 0.07% |
3,402,654
+144,100
| +4% | +$3.42M |
|
|
WNS
296
DELISTED
WNS Holdings
WNS
| $82.9M | 0.07% |
1,508,000
-157,400
| -9% | -$7.51M |
|
|
AZPN
297
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $82.9M | 0.07% |
799,703
-302,100
| -27% | -$31.3M |
|
298
Sabesp
SBS
$17.9B
| $82.8M | 0.07% |
40,633,114
-6,613,240
| -14% | -$11.1M |
|
299
Kimberly-Clark
KMB
$35.9B
| $82.7M | 0.07% |
585,175
+24,260
| +4% | +$3.35M |
|
300
Tandem Diabetes Care
TNDM
$1.62B
| $82.6M | 0.07% |
835,428
+340,500
| +69% | +$27.2M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.